| For: | Zhou YM, Cao YH, Guo J, Cen LS. Potential prospects of Chinese medicine application in diabetic retinopathy. World J Diabetes 2024; 15(10): 2010-2014 [PMID: 39493560 DOI: 10.4239/wjd.v15.i10.2010] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i10/2010.htm |
| Number | Citing Articles |
| 1 |
Xinying Hu, Zhe Cha, Ao Lu, Wuping Xu, Xiaoqing Zhang, Sheng Miao, Haiwei Xu, Xuedong Xu. Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence. MedComm 2026; 7(7) doi: 10.1002/mco2.70849
|
| 2 |
Na Liu, Wei-Tao Yan, Kun Xiong. Plantamajoside: A potentially novel botanical agent for diabetes mellitus management. World Journal of Diabetes 2025; 16(5): 104311 doi: 10.4239/wjd.v16.i5.104311
|
| 3 |
Huan Li, Xiong Huang. Advances in the molecular signaling mechanisms of VEGF/VEGFR2 in fundus neovascularization disease (Review). Experimental and Therapeutic Medicine 2025; 30(1) doi: 10.3892/etm.2025.12893
|
| 4 |
Sichen Yang, Guoyan Mo, Xinxin Pi, Tao Xiong, Long Cheng, Yan Meng, Junjie Hu, Weizhong Jiang, Zhaohua Shi. Unraveling the Therapeutic Mechanisms of Shanzhen Mingmu Pill in Diabetic Retinopathy: An Integration of Serum Pharmacochemistry, Network Pharmacology, and Experimental Validation. Phytochemical Analysis 2026; 37(2) doi: 10.1002/pca.70038
|
| 5 |
Jinmiao Chai, Wanwei Gui, Junlong Zhang, Wenbin He, Qinqing Li. Anti-diabetic retinopathy molecular mechanism of Dihuang Yinzi: insights from network pharmacology, metabolomics, and microbiome analysis. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1793936
|